Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials

J Clin Immunol. 2017 Aug;37(6):517-518. doi: 10.1007/s10875-017-0410-x. Epub 2017 Jul 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clinical Trials as Topic
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunologic Deficiency Syndromes / drug therapy*
  • Immunosuppressive Agents / therapeutic use*
  • Injections, Subcutaneous
  • North America
  • Research Design

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents